Description

The staging system for myeloma used by Acute Leukemia Group B and the Eastern Cooperative Oncology Group for comparing chemotherapy regimens is similar to other staging systems.


 

Good risk - all of the following are present:

(1) blood urea nitrogen <= 30 mg/dL

(2) serum calcium <= 12 mg/dL

(3) no significant infection at the time of diagnosis

(4) white blood cell count >= 4,000/µL and platelet count >= 100,000/µL

(5) clinical estimate of likely survival > 2 months

 

Poor risk - one or more of the above "good risk" features not present:

(1) blood urea nitrogen > 30 mg/dL

(2) serum calcium > 12 mg/dL

(3) significant infection at the time of diagnosis

(4) white blood cell count < 4,000/µL or platelet count < 100,000/µL

(5) clinical estimate of likely survival <= 2 months

 


To read more or access our algorithms and calculators, please log in or register.